Puromycin

Puromycin is an aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome. Among its listed roles, it functions as a nucleoside antibiotic, an antiinfective agent, an antineoplastic agent, a protein synthesis inhibitor, an antimicrobial agent, an EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor and an EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor. It is the conjugate base of puromycin(1+). It is grouped under the following drug class(es): Trypanosomiasis agents. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include 3′-(L-alpha-Amino-p-methoxyhydrocinnamamido)-3′-deoxy-N, N-dimethyladenosine, 3′-deoxy-N and N-dimethyl-3′-(O-methyl-L-tyrosinamido)adenosine. Its PubChem CID is 439530.

CAS No 53-79-2
Molecular Formula C22H29N7O5
Molecular Weight 471.5 g/mol
Synonyms (2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide

Frequently Asked Questions